??? Bioparc Bordeaux Métropole F Pessac CNRS. Poietis

Size: px
Start display at page:

Download "??? Bioparc Bordeaux Métropole F Pessac CNRS. Poietis"

Transcription

1 ??? Bioparc Bordeaux Métropole F Pessac 1 / 23

2 Company Profile Business: Provide patients and clinicians with Regenerative Medicine Therapies based on Laser-Assisted Bioprinting Overview Founded in Sept Key Milestones INSERM spin-off Seed Capital Funding ( 1,3m) Located in Bordeaux, France 100 m² clean room lab I-LAB 2014 World Innovation Challenge 2016 (Phase I) 22 FTE (incl. 18 researchers) Partnerships with world-class leaders: BASF, L'Oréal IP: 7 patent families 2 / 23

3 Company Background Spun-out from pioneer lab. at INSERM, one of the largest government-funded life sciences Institute in EU Cell printing 1st Bioprinter 1st Bioprinting in vivo Modeling Project Bone Printing 3D Bioprinter 1st Laser Bioprinting company International Conference Bioprinting and Biofabrication 3 in Bordeaux (3B 09) 3 / 23

4 Interdisciplinary team Arthur Douillet, Data Modeling Aude Clapies, Bioengineering Bertrand Viellerobe PhD, CTO Bruno Brisson, CBO Caroline Sion, Cell Biology Claire Poiron, Cell Biology Delphine Fayol PhD, CPO Etienne Pagin, Tissue production Evarzeg Le Bouffant, Opto-mechanics Fabien Guillemot PhD, CEO & CSO Guillaume Simon, Software Guillaume Vandeneeckhoutte, Software Jennifer Garnier, Quality Management Jérôme Bouter, Laser Process Laurent van Steenkiste, Marketing Dir. Lydie Pilorget, Business Intelligence Marc Nicodeme PhD, Image Analysis Marie Lassalle, Admin & Finances Marine Salducci, Cell Biology Mikael Garcia PhD, Cell Biology Romain Vaucelle, Image Processing 4 4 / 23

5 Bioprinting Market Market: 8bn in 2025 (CAGR >16 % / Y from 2015) Source: Research&Markets Tissue product issues: Tissue Complexity The translation of scaffold-based tissue engineering therapies to clinical used remains a failure Vascularization S. Hollister, Tissue Eng. Part B Reviews (2011) Personalization Safety Regulatory compliance Cost-effectiveness 5 Few products into the EU market: - ChondroCelect - MACI - Holoclar 5 / 23

6 Tissue complexity Dynamic interactions between: (stem)-cells, morphogens and extracellular matrix Tissue formation Cell fate Griffith et al, Nature Rev. Mol. Cell Biol (2009) Lecuit & Le Goff, Nature (2007) cell level: nanotopography stiffness ligand density growth factors cell neighbors Homeostasis tissue level: 6 migration, polarization, sorting, gradients patterns 6 / 23

7 Relation between form and function McBeath et al. Dev. Cell (2004) Peerani et al. EMBO J, (2007) Creating adequate geometries of cells, cues, ECM (or even drugs) defined at the cellular scale. Engineering complex7and functional tissues Winer and Janmey, PlosOne (2009) 7 / 23

8 htp:// Bioprinting = 3D Printing + Biology the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order 8 to produce bio-engineered structures serving in regenerative medicine, pharmacology and basic cell biology studies. F. Guillemot, V. Mironov & M. Nakamura, Biofabrication (2010) 8 / 23

9 Competitive Landscape Laser Cell concentration (millions / ml) Bioextrusion Microvalve Ink-jet Resolution (µm) 9 / 23

10 Why resolution matters? Standardization Bioextrusion Laser-Assisted Bioprinting Safety Morphogenesis Control Complexity Functionality Patient-specific / 23

11 4D Bioprinting Platform To design and bioprint tissues at Single-Cell Resolution New standard in tissue manufacturing / 23

12 Cytocentric CAD / 23

13 Cytocentric CAD / 23

14 NGBNGB bioprinter Sterile Multi-modal 8-axis translation stage Control of T, hygrometry In line imaging control of cell deposition User-friendly interface / 23

15 Bioprinting of skin models Laser assisted bioprinting (LAB) 10 µm Poietis Bioprinter Microvalve printing ECM µm µm 15 / 23

16 Control of dermis bioprinting sequence F1 - Fibroblasts C2 - Collagen F2 - Fibroblasts 500 µm 500 µm 500 µm 500 µm 500 µm 500 µm 16 Cell pattern is maintained Precise positioning 16 / 23

17 What do we learn from time-lapse imaging? / 23

18 Self-assembly depends on cell type 1h 24h 48h 72h Human Corneal fibroblasts hadscs Human melanoma cells 18 Human Skin fibroblats 18 / 23

19 4D bioprinting paradigm Programming self-organisation from 1D to 4D Design appropriate 3D micropatterns of tissue components (cells, ECM ) to drive self-organisation so that specific tissue function emerges with time 1 Precision 2 Resolution 3 Layering 4 Self-organisation 19 / 23

20 Bioprinting in vivo, in situ Bioprinting mesenchymal stem cells into mouse critical size bone calvaria defect / 23

21 Effect of cell patterns on bone healing Day 0 Day 5 Day 0 Day 5 21 control control 21 / 23

22 4D bioprinting paradigm Programming self-organisation from 1D to 4D Design appropriate 3D micropatterns of tissue components (cells, ECM ) to drive self-organisation so that specific tissue function emerges with time 1 Precision 2 Resolution 3 Layering 4 Self-organisation + considering interactions with host (external) 22 / 23

23 Bioprinting vs. 3D cell culture? Specificities : Similarities - Cell sourcing / preparation / characterization - Printable ECM - Appropriate culture media - Bioprinter parameters - Computer Design of 3D tissues - Guiding self-organization: more than a robotic pipette! Benefits (on going) - Precise control of initial cell locations in 3D (by design + in line controls) Non planar DEJ - Reproductibility - Reduction of fabrication time - Customization and complexification µm 23 / 23

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s

More information

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD.

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD. Horizon 2020 funding opportunities for Regenerative Medicine (2018-2020) Rudolf Fryček, PhD. Disclaimer: Any information mentioned is preliminary only, always consult the official documents. 1 Outline

More information

ENGINEERING 3D TISSUE SYSTEMS TO BETTER MIMIC HUMAN BIOLOGY

ENGINEERING 3D TISSUE SYSTEMS TO BETTER MIMIC HUMAN BIOLOGY ENGINEERING 3D TISSUE SYSTEMS TO BETTER MIMIC HUMAN BIOLOGY Matthew Gevaert, Ph.D. CEO matt.gevaert@kiyatec.com The Scientific Method is GREAT! Observation Hypothesis Test F = GMm r 2 Accept Hypothesis

More information

Break the 3D barrier CORNING 3D CELL CULTURE

Break the 3D barrier CORNING 3D CELL CULTURE Break the 3D barrier VESSELS SURFACES MEDIA CORNING 3D CELL CULTURE Get there fast with 3D cell culture. Whether you re just getting started in 3D cell culture, looking for proven ways to scale up, or

More information

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015

E&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015 E&T objectives in evolving pharma business models Magda Chlebus Director Science Policy Brussels, 2 March 2015 Education adapted to demand? Declining number of students choosing science Education still

More information

Cell-Environment Interactions. Chieh-Chun Chen

Cell-Environment Interactions. Chieh-Chun Chen Cell-Environment Interactions Chieh-Chun Chen Part 1: Soft Lithography in Biology and Biochemistry Chieh-Chun Chen Outlines Introduction Key features of soft lithography Applications In microscopic biochemical

More information

Tissue engineering. Langer R, Vacanti JP. Tissue engineering. Science 1993, 260(5110),

Tissue engineering. Langer R, Vacanti JP. Tissue engineering. Science 1993, 260(5110), Biofabrication Tissue engineering an interdisciplinary field that applies the principles of engineering and life sciences towards the development of biological substitutes that restore, maintain, or improve

More information

CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE

CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE CENTRE DE THÉRAPIE TISSULAIRE & CELLULAIRE CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE Pr. D. Dufrane MD, PhD 3D-BIOPRINTING: MYTH OR REALITY? 2 REGENERATIVE MEDICINE FOR ORGAN AND TISSUE A LARGE

More information

Looking Ahead: The Bio-Artificial Kidney

Looking Ahead: The Bio-Artificial Kidney Looking Ahead: The Bio-Artificial Kidney Teja Guda, PhD Assistant Professor, Department of Biomedical Engineering Assistant Director, Center for Innovation Technology and Entrepreneurship University of

More information

1) Determining the best cell sources and scaffold materials for TEHV development.

1) Determining the best cell sources and scaffold materials for TEHV development. Broadly speaking, my primary research interests focus on the development and application of methodologies that can be employed in the basic understanding and optimization of tissue engineered heart valves

More information

For personal use only

For personal use only Quarterly Cash Flow Report June 2016 Perth, Australia; 29 April 2016: Orthocell Limited s Quarterly Cash Flow Report for the quarter ended 30 June 2016 is attached. Orthocell is a commercial-stage, regenerative

More information

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website] SCM Lifescience [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea 22332 [Website] http://www.scmlifescience.com COMPANY PROFILE [Industry] SCM Lifescience is a research-based biopharmaceutical company

More information

Prof. Steven S. Saliterman

Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Angela Panoskaltsis-Mortari s BMEn 5361, 3D Bioprinting Tissue engineering Bioprinting Design considerations

More information

Sabrina Jedlicka. Interactions of Neurons and Materials

Sabrina Jedlicka. Interactions of Neurons and Materials Sabrina Jedlicka Interactions of Neurons and Materials Developmental Cell Biology Some Perspective Stem cells: Undifferentiated cells that are capable of proliferation, self-maintenance and differentiation

More information

Regenovo 3D Bioprinter. Beyond imagination Print future

Regenovo 3D Bioprinter. Beyond imagination Print future Regenovo 3D Bioprinter Beyond imagination Print future Features: The introduction of : Regenovo Biotechnology Co.,Ltd. is a high-tech enterprises that provide professional integrated solutions in 3D printing

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE Massachusetts Institute of Technology Harvard Medical School Brigham and Women s Hospital VA Boston Healthcare System 2.79J/3.96J/20.441/HST522J UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE

More information

EMA s role & responsibility for the development of modern/advanced therapies

EMA s role & responsibility for the development of modern/advanced therapies EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory

More information

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Stem Cell Services. Driving Innovation for Stem Cell Researchers Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,

More information

Kieran McGourty, PhD. Short BIO. Long BIO

Kieran McGourty, PhD. Short BIO. Long BIO Kieran McGourty, PhD Lecturer in Biochemistry and Cell Biology, Department of Chemical Sciences University of Limerick, Ireland Short BIO Kieran did his PhD and his Post-Doctoral scientific training in

More information

6/18/ D Co-print of Epoxy Resin with Cellladen Bioink for Custom Shaped Nipple-Areola Skin Grafts. 3D Printing Workshop 6/8/2018

6/18/ D Co-print of Epoxy Resin with Cellladen Bioink for Custom Shaped Nipple-Areola Skin Grafts. 3D Printing Workshop 6/8/2018 Case Study: D extrusion-based printing D Co-print of Epoxy Resin with Cellladen Bioink for Custom Shaped Nipple-Areola Skin Grafts Sarah Van Belleghem D Printing Workshop 6/8/2018 WELCOME D PRINTING WORKSHOP

More information

Course Handbook MSc in Bioengineering Tissue Engineering Specialisation

Course Handbook MSc in Bioengineering Tissue Engineering Specialisation Course Handbook 2013-2014 MSc in Bioengineering Tissue Engineering Specialisation 1 Course Objectives & Learning Outcomes This programme aims to give a sound and broad basis in tissue engineering. In particular,

More information

3D Cell Culture Product Intro. Bio-Byblos Biomedical

3D Cell Culture Product Intro. Bio-Byblos Biomedical 3D Cell Culture Product Intro Bio-Byblos Biomedical Rundown Product Intro Cellusponge Series Go Matrix Applications Upcoming Products Degradable series Cellusponge CB series Cell Alignment plate Vivoalign

More information

Biomedical Engineering 3D BIOPRINTING OF SILK FOR CELLULAR APPLICATIONS. Martina Ravizza

Biomedical Engineering 3D BIOPRINTING OF SILK FOR CELLULAR APPLICATIONS. Martina Ravizza Biomedical Engineering 3D BIOPRINTING OF SILK FOR CELLULAR APPLICATIONS Martina Ravizza Supervisor: Prof. Ferdinando Auricchio Correlator: Dott. Michele Conti Sericina Fibroina Academic year 2014/2015

More information

USAMRMC STRATEGIC COMMUNICATION PLAN ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE (AFIRM)

USAMRMC STRATEGIC COMMUNICATION PLAN ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE (AFIRM) ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE (AFIRM) MISSION The Armed Forces Institute of Regenerative Medicine is dedicated to repairing battlefield injuries through the use of regenerative medicine

More information

Journey from a Small University Lab to Bringing New Therapy to the Patient s Bedside

Journey from a Small University Lab to Bringing New Therapy to the Patient s Bedside Journey from a Small University Lab to Bringing New Therapy to the Patient s Bedside David T. Woodley, M.D. & Mei Chen Ph.D USC Department of Dermatology Dermatology Innovation Forum February 28 th, 2019,

More information

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. Anika Therapeutics, Inc. Jefferies Global Healthcare Conference June 4, 2015 Safe Harbor Statement The statements made in this presentation that are not statements of historical fact are forward looking

More information

Stem Cell Research From Bench to Bedside

Stem Cell Research From Bench to Bedside Stem Cell Research From Bench to Bedside Stem Cell Dialogues Jan A. Nolta, Ph.D. Professor, Internal Medicine Director, UC Davis Institute for Regenerative Cures October 26, 2010 Stem Cells at UC Davis

More information

Disclosure-Yaszemski

Disclosure-Yaszemski Current and Future Uses of Additive Manufacturing in Neurologic, Musculoskeletal, Spinal, and Oncologic Surgery Michael J. Yaszemski, M.D., Ph.D. John & Posy Krehbiel Endowed Professor of Orthopedic Surgery

More information

Bioengineering Research Map

Bioengineering Research Map Bioengineering Research Map Lee Makowski, Professor and Chair l.makowski@northeastern.edu Mark Niedre, Associate Professor and Associate Chair For Research m.niedre@northeastern.edu Chloe Tolman, Academic

More information

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials Sabrina Jedlicka 9/24/2012 NEUROENGINEERING: Interactions of Neurons and Materials What is neuroengineering? Neuroengineering combines engineering and computational approaches to problems in basic and

More information

The Design of Droplet Based Bioprinting Systems for Reliable Bioink Delivery

The Design of Droplet Based Bioprinting Systems for Reliable Bioink Delivery The Design of Droplet Based Bioprinting Systems for Reliable Bioink Delivery Matthew Benning School of Mechanical in Systems Engineering Newcastle University Introduction Our Research Aim and Objectives

More information

ERISTO: European Research In Space and Terrestrial Osteoporosis

ERISTO: European Research In Space and Terrestrial Osteoporosis ERISTO: European Research In Space and Terrestrial Osteoporosis Part of the European Space Agency - Microgravity Application Program. The project is focused on the effects of mechanical stress on bone

More information

Methods in Bioengineering: 3D Tissue Engineering

Methods in Bioengineering: 3D Tissue Engineering Methods in Bioengineering: 3D Tissue Engineering Berthiaume, Francois ISBN-13: 9781596934580 Table of Contents Preface Chapter 1. Chemical Modification of Porous Scaffolds Using Plasma Polymers 1.1. Introduction

More information

Sabrina Jedlicka. Interactions of Neurons and Materials

Sabrina Jedlicka. Interactions of Neurons and Materials Sabrina Jedlicka Interactions of Neurons and Materials Neurological Disorders Over 600 known neurological disorders ú Diseases of the CNS and PNS Epilepsy Alzheimer s Parkinson s Etc. ú Diseases that attack

More information

LIFE Formation III. Morphogenesis: building 3D structures START FUTURE. How-to 2 PROBLEMS FORMATION SYSTEMS SYSTEMS.

LIFE Formation III. Morphogenesis: building 3D structures START FUTURE. How-to 2 PROBLEMS FORMATION SYSTEMS SYSTEMS. 7.013 4.6.07 Formation III Morphogenesis: building 3D structures VIRUSES CANCER HUMAN DISEASE START SYSTEMS BIOLOGY PROBLEMS FUTURE LIFE IMMUNE NERVOUS SYSTEMS How-to 1 FOUNDATIONS How-to 2 REC. DNA BIOCHEM

More information

Affinity. A Paradigm Shift in Skeletal Reconstruction

Affinity. A Paradigm Shift in Skeletal Reconstruction Affinity A Paradigm Shift in Skeletal Reconstruction INTRODUCING TRS AFFINITY SKELETAL RECONSTRUCTION BREAKTHROUGH Tissue Regeneration Systems (TRS ) is a start-up medical device company commercializing

More information

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength. RegenACR autologous cellular regeneration RegenACR A-PRP treatment collagen fibers. 1,2 texture and elasticity. 3 volume & strength. 4,5 WHAT IS A-PRP Autologous Platelet Rich Plasma Plasma contains many

More information

Bioprinting at the Naval Research Laboratory. Bradley Ringeisen, Ph.D. Head, Bioenergy and Biofabrication Section Chemistry Division

Bioprinting at the Naval Research Laboratory. Bradley Ringeisen, Ph.D. Head, Bioenergy and Biofabrication Section Chemistry Division Bioprinting at the Naval Research Laboratory Bradley Ringeisen, Ph.D. Head, Bioenergy and Biofabrication Section Chemistry Division 1 What is bioprinting? Bioprinting is the controlled deposition of any

More information

Changing the Shape of Medical Research and Practice

Changing the Shape of Medical Research and Practice Changing the Shape of Medical Research and Practice Keith Murphy Chief Executive Officer Copyright 2014, Organovo Holdings, Inc. This report is solely for the use of intended audience. No part of it may

More information

Regenerative and Immune Engineering Focus Area Upper-Level Engineering Courses updated October, 2018 For BME Class of 2021 and beyond

Regenerative and Immune Engineering Focus Area Upper-Level Engineering Courses updated October, 2018 For BME Class of 2021 and beyond Regenerative and Immune Engineering Focus Area Upper-Level Engineering Courses updated October, 2018 For BME Class of 2021 and beyond EN.510.311 Structure of Materials 3 EN.510.312 Thermodynamics/Materials

More information

Regenerative and Immune Engineering Focus Area - Upper-Level Engineering Courses updated June, 2018 For BME Class of 2021 and beyond

Regenerative and Immune Engineering Focus Area - Upper-Level Engineering Courses updated June, 2018 For BME Class of 2021 and beyond Regenerative and Immune Engineering Focus Area - Upper-Level Engineering Courses updated June, 2018 For BME Class of 2021 and beyond EN.510.311 Structure of Materials 3 EN.510.312 Thermodynamics/Materials

More information

PROJECT FINAL REPORT

PROJECT FINAL REPORT PROJECT FINAL REPORT "Publishable" Grant Agreement number: 257073 Project acronym: PASCA Project title: Platform for Advanced Single Cell-Manipulation and Analysis Funding Scheme: STREP Period covered:

More information

Vevo The Ultimate Preclinical Imaging Experience

Vevo The Ultimate Preclinical Imaging Experience The Ultimate Preclinical Imaging Experience 2 Introducing The World s First One-Touch Preclinical Imaging Platform The is a new and innovative platform created for the future of imaging. It combines ultra

More information

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR > SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders

More information

Centre for NanoHealth

Centre for NanoHealth Steve Conlan PhD An integrated collaborative base for businesses in Wales Director - Reproductive Biology & Cancer Research Institute of Life Science School of Medicine Unique interdisciplinary R&D environment,

More information

Cellular Matrix HYDRATION & REGENERATION. Autologous Platelet Rich Plasma combined with Hyaluronic Acid for Skin Regeneration

Cellular Matrix HYDRATION & REGENERATION. Autologous Platelet Rich Plasma combined with Hyaluronic Acid for Skin Regeneration Cellular Matrix HYDRATION & REGENERATION Autologous Platelet Rich Plasma combined with Hyaluronic Acid for Skin Regeneration A-PRP & HA Autologous Platelet Rich Plasma Hyaluronic Acid Cellular Matrix is

More information

REMEDI. Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland GENERAL PRESENTATION. Director: Prof. Frank Barry

REMEDI. Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland GENERAL PRESENTATION. Director: Prof. Frank Barry Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland Director: Prof. Frank Barry GENERAL PRESENTATION Contact person in NEWGEN: Dr. Jessica Hayes Working Group Involvement: Member of Working Group

More information

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Mimicking the fibrillar structure of the extracellular matrix is important for scaffolds. Clinical trails to date

More information

TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS

TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS HLC101B August 2014 Yojana Jeevane Project Analyst ISBN: 1-56965-894-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA

More information

White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations. Peter D. Gabriele Director, Emerging Technology

White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations. Peter D. Gabriele Director, Emerging Technology White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations Peter D. Gabriele Director, Emerging Technology Regenerative medicine (RM) holds the potential to address some

More information

FOR IMMEDIATE RELEASE

FOR IMMEDIATE RELEASE FOR IMMEDIATE RELEASE Media Contact: Melanie Battista, Public Relations (TSX-V: LBL) (OTCBB: BLVKF) 16701 N 90th Street, Suite#101 Scottsdale, AZ 85260 480-563-0800 Office News@LatticeBiologics.com www.latticebiologics.com

More information

Early Stage Researcher (ESR) position for research on Pre-clinical studies on neurotransmitter replacement in the basal ganglia for PD and HD

Early Stage Researcher (ESR) position for research on Pre-clinical studies on neurotransmitter replacement in the basal ganglia for PD and HD Early Stage Researcher (ESR) position for research on Pre-clinical studies on neurotransmitter replacement in the basal ganglia for PD and HD Applications are invited from suitably qualified candidates

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells

More information

WINTHER TRIAL: AN SME DRIVEN EUFP7 PROGRAM TO CREATE AN INDUSTRY STANDARD TOOL TO OPTIMIZE THERAPEUTIC DECISION MAKING

WINTHER TRIAL: AN SME DRIVEN EUFP7 PROGRAM TO CREATE AN INDUSTRY STANDARD TOOL TO OPTIMIZE THERAPEUTIC DECISION MAKING WINTHER TRIAL: AN SME DRIVEN EUFP7 PROGRAM TO CREATE AN INDUSTRY STANDARD TOOL TO OPTIMIZE THERAPEUTIC DECISION MAKING Mohammad Afshar, MD, PhD Ariana Pharma WIN Symposium June 2015 - Paris Disclosure

More information

Stem cell and cell therapeutics research in Lithuania. Bernardas Morkunas Head of Business Development

Stem cell and cell therapeutics research in Lithuania. Bernardas Morkunas Head of Business Development Stem cell and cell therapeutics research in Lithuania Bernardas Morkunas Head of Business Development Lithuanian biotech Biotechnology is considered as one of 2014-2020 Smart Specialisation priority fields

More information

In Vitro Assembly of 3D Bile Duct Networks within Decellularized Extracellular Matrix Hydrogels

In Vitro Assembly of 3D Bile Duct Networks within Decellularized Extracellular Matrix Hydrogels In Vitro Assembly of 3D Bile Duct Networks within Decellularized Extracellular Matrix Hydrogels Phillip Lewis, MS Department of Biomedical Engineering Northwestern University In Vitro Assembly of 3D Bile

More information

SCIENTIFIC ANALYSIS AND ENDORSEMENT OF NITTA CASINGS COLLAGEN GEL

SCIENTIFIC ANALYSIS AND ENDORSEMENT OF NITTA CASINGS COLLAGEN GEL SCIENTIFIC ANALYSIS AND ENDORSEMENT OF NITTA CASINGS COLLAGEN GEL 12/26/2017 For Nitta Casings TABLE OF CONTENTS About Dr. Silvia Minardi 2 Background on Collagen.. 3 Analysis of NITTA GEL. 3 Endorsement

More information

International Foundations of Medicine Basic Science Exam Blueprint

International Foundations of Medicine Basic Science Exam Blueprint International Foundations of Medicine Basic Science Exam Blueprint General Principles 28% 30% Biochemistry and molecular biology gene expression: DNA structure, replication, and exchange gene expression:

More information

Nanotechnology and Advanced Materials for more effective Healthcare

Nanotechnology and Advanced Materials for more effective Healthcare Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics

More information

Building the Europe of Knowledge

Building the Europe of Knowledge Building the Europe of Knowledge 7 th Framework Programme 2007-2013 Nanotechnology! All information preliminary! FP7 1. Capacities: Infrastructures 2. People: Erasmus, Marie-Curie 3. Ideas: ERC 4. Cooperation:

More information

White Paper Authentic Recombinant Activin A and BMP- 4 Production Using HumanZyme s Proprietary Human Cell Line Expression Technology

White Paper Authentic Recombinant Activin A and BMP- 4 Production Using HumanZyme s Proprietary Human Cell Line Expression Technology White Paper Authentic Recombinant Activin A and BMP- 4 Production Using HumanZyme s Proprietary Human Cell Line Expression Technology Mark Azam, Ph.D. VP - R&D and Manufacturing Patricia Ahrweiler, Ph.D.

More information

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003 Lecture 6: Biodegradable Polymers for Tissue Engineering Last time: Today: enzymatic degradation of solid polymers Engineering biological recognition of polymers Designing polymers for tissue engineering

More information

Vevo The Ultimate Preclinical Imaging Experience

Vevo The Ultimate Preclinical Imaging Experience Vevo 3100 The Ultimate Preclinical Imaging Experience 2 3 Introducing The World s First One-Touch Preclinical Imaging Platform The is a new and innovative platform created for the future of imaging. It

More information

9/15/2017. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

9/15/2017. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Angela Panoskaltsis-Mortari s BMEn 5920, Special Topics in 3D Bioprinting Tissue engineering Pathway for bioprinting

More information

Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop

Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop Board on Health Sciences Policy Forum on Regenerative Medicine Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop October 18, 2018 National

More information

Defining the final therapeutic product - formulation, container, administration

Defining the final therapeutic product - formulation, container, administration Defining the final therapeutic product - formulation, container, administration Marc Barthold Miltenyi Biotec GmbH 16th Meeting of ISCT, Philadelphia, 2010 1 Final formulation of cell based therapies Cell

More information

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden Nanosystems in regenerative medicine Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden Outline Motivation for tissue regeneration Cell based approaches Material based

More information

Medical Devices: Engineering s Contributions to the Quality of Life

Medical Devices: Engineering s Contributions to the Quality of Life Medical Devices: Engineering s Contributions to the Quality of Life Guna Selvaduray San Jose State University inemi Medical Electronics Workshop Santa Clara, California May 4 5, 2011 Presentation Outline

More information

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic

More information

Harvard Stem Cell Institute

Harvard Stem Cell Institute Welcome to the Harvard Stem Cell Institute The 1000+ scientists in the HSCI network share one goal: finding cures for human diseases. We aim to: Stimulate healing in patients by harnessing the potential

More information

Functional Assessment and Clinical Outcome

Functional Assessment and Clinical Outcome Tissue Engineering Functional Assessment and Clinical Outcome STEVEN A. GOLDSTEIN Orthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan 48109,

More information

Growth factor delivery

Growth factor delivery Growth factor delivery S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs

More information

DESIGN AND FABRICATION OF ARTIFICIAL SKIN USING EMBEDDED MICROCHANNELS AND LIQUID CONDUCTORS

DESIGN AND FABRICATION OF ARTIFICIAL SKIN USING EMBEDDED MICROCHANNELS AND LIQUID CONDUCTORS ONLY AND OF USING EMBEDDED MICROCHANNELS AND LIQUID CONDUCTORS ONLY Critical technology. Robots are expected to work more autonomously. Biomedical science has made a lot of progress. The robotics community

More information

Present and future of regenerative medicine. Liver Transplantation

Present and future of regenerative medicine. Liver Transplantation Present and future of regenerative medicine Liver Transplantation Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 19, 2015 Introduction Strategies to increase the number of organs EXPAND

More information

Development of new polymeric biomaterials for in vitro and in vivo liver reconstruction

Development of new polymeric biomaterials for in vitro and in vivo liver reconstruction SIXTH FRAMEWORK PROGRAMME PRIORITY 3 NMP- Nanotechnology and nano sciences, knowledge-based multifunctional materials and new production processes and devices Development of new polymeric biomaterials

More information

3D In Vitro Living Systems for Biological Application

3D In Vitro Living Systems for Biological Application 3D In Vitro Living Systems for Biological Application Hossein Hosseinkhani Graduate Institute of Biomedical Engineering, National Taiwan University of Science and Technology (TAIWAN TECH), Taipei, Taiwan

More information

EUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008

EUROPEAN TECHNOLOGY PLATFORM NANOMEDICINE. Work plan for GA, 16th January 2008 Work plan for 2008 1 Vision In 10 years nanomedicinebased products will lead to breakthroughs in the treatment of diseases such as cardiovascular disease, cancer, CNS diseases and diabetes. 2 The ETP is

More information

Monteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA

Monteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA Monteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA Introduction: Cell migration is a ubiquitous process that is of fundamental

More information

Preclinical development for SSc indications NO COPY. a preclinical portfolio in a perfect world. Jörg Distler

Preclinical development for SSc indications NO COPY. a preclinical portfolio in a perfect world. Jörg Distler Preclinical development for SSc indications a preclinical portfolio in a perfect world Jörg Distler Department of Internal Medicine 3 and Institute for Clinical Immunology University of Erlangen-Nuremberg

More information

Determining the Predictive Validity of 3D Models & Achieving Standardization for Preclinical Efficacy Testing

Determining the Predictive Validity of 3D Models & Achieving Standardization for Preclinical Efficacy Testing Determining the Predictive Validity of 3D Models & Achieving Standardization for Preclinical Efficacy Testing August 28 2017 Jason Ekert, Head of Complex In Vitro Models Platform Technology and Sciences

More information

10:10-10:22. YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32

10:10-10:22. YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32 10:10-10:22 YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32 EPA-1 Integration of conventional cell viability assays- recruiting

More information

20 years. Healed! What did he say? Just got home from the doctor. How s Dad?

20 years. Healed! What did he say? Just got home from the doctor. How s Dad? 2 0 1 2 A N N U A L R E P O R T How s Dad? Just got home from the doctor. What did he say? Healed! 20 years of stem cell research, development, and global leadership distilled into the only word that matters

More information

General Description of the project.

General Description of the project. 2 PhD scholarships in Pre-clinical studies on therapeutic factor delivery in the basal ganglia for PD and HD and Pre-clinical studies on neurotransmitter replacement in the basal ganglia for PD and HD

More information

Board on Health Sciences Policy. June 24, 2010 Institute of Medicine The Keck Center of the National Academies 500 Fifth Street NW Room 100.

Board on Health Sciences Policy. June 24, 2010 Institute of Medicine The Keck Center of the National Academies 500 Fifth Street NW Room 100. INSTITUTE OF MEDICINE THE NATIONAL ACADEMIES Board on Health Sciences Policy June 24, 2010 Institute of Medicine The Keck Center of the National Academies 500 Fifth Street NW Room 100 Agenda THURSDAY JUNE

More information

Some Trends in Health Technology

Some Trends in Health Technology Some Trends in Health Technology Christian ROUX Professor & Senior Vice-president for Research and Innovation Institut Mines-Télécom Outline n Introduction n Driving factors n Health continuum n Conclusion

More information

NPIMR. Progress for Patients.

NPIMR. Progress for Patients. www.npimr.org Our vision is to be recognised as a leading biomedical research and service organisation that seeks to radically improve outcomes and maximise benefits for patients and the wider NHS. We

More information

Prof. Steven S. Saliterman

Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Angela Panoskaltsis-Mortari s BMEn 5361, 3D Bioprinting Human scale bioprinting. 2D and 3D bioprinting Mandible

More information

hpsc Growth Medium DXF Dr. Lorna Whyte

hpsc Growth Medium DXF Dr. Lorna Whyte hpsc Growth Medium DXF Dr. Lorna Whyte 27.06.2014 Training from Heidelberg Overview Background: Stem Cells Introduction: Human Pluripotent Stem Cells (hpsc) vs. Adult Stem Cells Promise of PSC Research

More information

practice, few studies are available that clearly demonstrate the clinical benefit of 3D-printed materials(youssef et al., 2015).

practice, few studies are available that clearly demonstrate the clinical benefit of 3D-printed materials(youssef et al., 2015). 3D Printing Kidney These days, scientists are working on various complex technologies such as regenerative medicine and tissue engineering in order to produce transplantable organ and repair damaged organs

More information

Biomaterials in bone tissue regeneration and biofabrication: advances and challenges. Aldo R. Boccaccini

Biomaterials in bone tissue regeneration and biofabrication: advances and challenges. Aldo R. Boccaccini Biomaterials in bone tissue regeneration and biofabrication: advances and challenges Aldo R. Boccaccini Institute of Biomaterials Department of Materials Science and Engineering University of Erlangen-Nuremberg

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

Tissue Engineered Medical Products

Tissue Engineered Medical Products WORKSHOP 8 Tissue Organizer: Jeremy J. Rawlinson PhD Speakers: Jack E. Lemons, PhD Lawrence J. Bonassar, PhD Mauro R. Alini, PhD Michael J. Yaszemski, MD, PhD Standards for Tissue J. Lemons, University

More information

Revolutionising Stem Cell Research. Unique Biaxial Bioreactor Designed for TISSUE ENGINEERING & 3D CELL CULTURE. Regeneration System

Revolutionising Stem Cell Research. Unique Biaxial Bioreactor Designed for TISSUE ENGINEERING & 3D CELL CULTURE. Regeneration System Regeneration System Unique Biaxial Bioreactor Designed for TISSUE ENGINEERING & 3D CELL CULTURE Revolutionising Stem Cell Research A Member of Quintech Life Sciences TisXell A Renaissance in Regenerative

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

The response of research: from the field to the lab. K. Victoir PhD

The response of research: from the field to the lab. K. Victoir PhD The response of research: from the field to the lab K. Victoir PhD Outline Responses to the Ebola outbreak: a nations response (France) and an institutional response (IP) Overview of the Field actions

More information

Biopreservation Tools for Cells, Tissues and Organs

Biopreservation Tools for Cells, Tissues and Organs Biopreservation Tools for Cells, Tissues and Organs NASDAQ: BLFS Investor Presentation March 2018 Safe Harbor Statement Except for historical information contained herein, this press release contains forward-looking

More information

Tissue Engineering and Regenerative Medicine

Tissue Engineering and Regenerative Medicine Tissue Engineering and Regenerative Medicine NIH Center for Engineering Complex Tissues (CECT) June 8, 2018 Bhushan Mahadik, Ph.D. Assistant Director, CECT University of Maryland Regenerative Medicine

More information

Printing of biochemically-patterned slides with the InnoStamp40 for deterministic cell immobilization.

Printing of biochemically-patterned slides with the InnoStamp40 for deterministic cell immobilization. Printing of biochemically-patterned slides with the InnoStamp40 for deterministic cell immobilization. Jean christophe CAU 1 1 Innopsys, Parc activestre, Carbonne France contact@innopsys.fr www.innopsys.com

More information